Rejuvenate Biomed are ready to take their first Longevity therapy into clinical trials: Invest, buy, or both?

It’s time to have your say on Rejuvenate Biomed.

We like Longevity therapies derived from existing ‘off-patent’ drugs and this is what Rejuvenate Biomed are doing; they’re de-risked, unencumbered by licensing complexities and have great results from their research … but that’s just our opinion – you’re the ones with the investment and buying potential: What do you think?

• Watch the video pitch and investor questions;
• Check-out the slide deck;
• Take the 30 secs survey and see what others think!

The video pitch and investor questions:

The slide deck:

The 30-second survey (with live results):

[wpforms id=”6141″]

Would you like to know more?

We’re happy to pass along your comments and questions to the Rejuvenate Biomed team: you can email us via this link. Thanks.

 
Thanks for engaging – we have regular Startup Showcases coming-up: stay tuned!